Author

Haig Inguilizian

Observed name: H V Inguilizian

Institution: Takeda (United States)

Observed institutions: Boston Children's Hospital, Dana-Farber Cancer Institute, Takeda (United States)

OpenAlex ID: A5042911522

Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma

2012 · Stefano Monti, Bjoern Chapuy, et al. · Cancer Cell · 207

Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency

2015 · Melissa P. Wasserstein, Simon A. Jones, et al. · Molecular Genetics and Metabolism · 112

The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia

2012 · Versha Banerji, Stacey M. Frumm, et al. · Journal of Clinical Investigation · 105

The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity

2011 · M M Reddy, M S Fernandes, et al. · Leukemia · 45

A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C

2023 · Richard Kim, Alexis D. Leal, et al. · Cancer Chemotherapy and Pharmacology · 19

Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C

2023 · Richard Kim, Alexis D. Leal, et al. · Cancer Chemotherapy and Pharmacology · 2

An open-label, multicenter, ascending-repeat-dose study of the tolerability and safety of recombinant human acid sphingomyelinase (rhASM) in patients with ASM deficiency (ASMD)

2015 · Melissa P. Wasserstein, Simon A. Jones, et al. · Molecular Genetics and Metabolism

A Structural Basis for p53-Deficiency, Deregulated Cell Cycle and Unfavorable Outcome in Diffuse Large B-Cell Lymphoma

2012 · Bjoern Chapuy, Stefano Monti, et al. · Blood

Intersecting Chemical Genomic and Genetic Screens Identifies Glycogen Synthase Kinase-3α (GSK-3α) as a Modulator of Differentiation In Acute Myeloid Leukemia

2010 · Versha Banerji, Kenneth N. Ross, et al. · Blood

Works count: 9

Citation count: 490

H-index: 5

I10-index: 5